Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Serum osteoprotegerin (OPG) le...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
Bibliographic Details
Main Authors:
Eaton, C
,
Wells, J
,
Holen, I
,
Croucher, P
,
Hamdy, F
Format:
Conference item
Published:
2004
Holdings
Description
Similar Items
Staff View
Similar Items
Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
by: Eaton, C, et al.
Published: (2004)
Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
by: Holen, I, et al.
Published: (2002)
Role of osteoprotegerin (OPG) in cancer.
by: Holen, I, et al.
Published: (2006)
Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
by: Holen, I, et al.
Published: (2002)
The role of osteoprotegerin in breast and prostate cancer
by: Holen, I, et al.
Published: (2002)